This inventor holds 1 USPTO granted patent and 6 published patent applications and 2 EPO patents. Top assignee: Casebia Therapeutics Limited Liability Partnership. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Philipp Knyphausen: Inventor in RNA-Programmable Endonuclease Systems.
Introduction
Philipp Knyphausen is an inventor associated with Cologne, Germany. His patent work includes research into RNA-programmable endonuclease systems, technologies relevant to gene editing.
Latest Patents
Knyphausen is named on one patent: “Novel High Fidelity RNA-Programmable Endonuclease Systems and Uses Thereof.” The patent concerns endonuclease systems designed for high-fidelity, RNA-guided applications.
Career Highlights
Knyphausen has been associated with Casebia Therapeutics Limited Liability Partnership and CRISPR Therapeutics AG. His patent record reflects work in the biotechnology and gene-editing field.
Collaborations
His listed coworkers include Andre Cohnen and Wayne Coco, reflecting professional connections in the biotechnology sector.
Conclusion
Philipp Knyphausen’s inventor profile centers on RNA-programmable endonuclease technology and his associations with biotechnology companies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile